skip to Main Content

Dr. Hochster on Take-Home Message of the POLO Trial in Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Howard S. Hochster, MD, FACP, associate director for clinical research and director, Gastrointestinal Oncology, Rutgers Cancer Institute of New Jersey, director of oncology research, RWJBarnabas Health, discusses important takeaways from the randomized, double-blind, phase III POLO trial in pancreatic cancer.

Watch here . . . 

Back To Top